Latest News

A genome-wide analyses in Nature Genetics identified 30 independent loci associated with obsessive–compulsive disorder, highlighting genetic overlap with other psychiatric disorders and implicating putative effector genes and cell types contributing to its etiology. Marco Galimberti, PhD, associate research scientist, is co-first author.

Angelina Spicer, a stand-up comic, producer, writer, and self-described “accidental activist,” was honored March 22, 2025 with the Yale Department of Psychiatry Mental Health Advocacy Award.

Christopher J. Pittenger, MD, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry, has been awarded a Distinguished Investigator Grant by the Brain & Behavior Research Foundation (BBRF).

Christopher Pittenger, MD, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry, and Anna Yusim, MD, assistant clinical professor of psychiatry, spoke to WTNH-TV News 8 about why December is a difficult time for some people with mental health struggles.

The Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²) has announced grants over $600,000 to 14 Yale School of Medicine researchers for innovative projects to understand the impact of cannabis and cannabinoids on neurodevelopment and mental health.

Christopher Pittenger, MD, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry, spoke to National Public Radio for a story about misconceptions surrounding obsessive-compulsive disorder. Pittenger is director of the Yale OCD Research Clinic.

Scientists from Yale School of Medicine, Yale School of Public Health, and Yale's Graduate School of Arts and Sciences have been awarded a $20.6 million federal grant for a five-year study of people with a wide range of mental illnesses.

To better understand the impact of NIH funding, U.S. Sen. Richard Blumenthal visited Yale School of Medicine for a tour of neuroscience lab facilities and a discussion with neuroscience researchers.

John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and professor of psychiatry, of neuroscience, and of psychology, and chair of the Yale Department of Psychiatry; and Christopher Pittenger, MD, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry, were among six psychiatric researchers, entrepreneurs, and healthcare industry professionals who participated in a panel during the 10th annual Yale Innovation Summit on May 30. The panel was titled "Biotech: Exploring The Psychedelic Renaissance."